The future of breast cancer screening and risk-reducing strategies is being shaped by artificial intelligence (AI), according to a review article published on December 12 in the journal Trends in ...

Less-frequent mammographic surveillance showed a similar recurrence-free interval. Evidence Rating Level: 1 (Excellent) Study ...

The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has reached its enrollment goal of 108,508 women, as announced ...